Table 1.
Scheme Used to Code the Combination of Clinical Divergence and Statistical Significance in Determining Strength of Evidence for Clinicostatistical Divergence (CSD) as an Objective Measure of the Presence or Absence of Heterogeneity of Treatment Effects (HTE)
| Clinical Divergence Present? | Statistical Significance Present? | Strength of Evidence for Clinicostatistical Divergence |
|---|---|---|
| No | No | None |
| No | * | None |
| * | No | None |
| Yes | No | Weak |
| Yes | * | Weak |
| No | Yes | Weak |
| * | Yes | Weak |
| Yes | Yes (without any prespecified covariates) | Moderate |
| Yes | Yes (with at least one prespecified covariate) | Strong |
| * | * | Unable to classify |
*
Data were not provided in the article.